|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 301 - 324 of 324 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Myastad 180 mg, 360 mg enterotabletti SPC 2024-04-02
|
|
|
|
European Medicines Agency's website:
Mycamine - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Mycapssa - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Myclausen - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Mycophenolate Hexal 500 mg tabletti, kalvopäällysteinen SPC 2024-04-05
|
|
PL
|
Resepti
|
Mycophenolate Mofetil Accord 250 mg kapseli, kova SPC 2024-04-12
|
|
PL
|
Resepti
|
Mycophenolate Mofetil Accord 500 mg tabletti, kalvopäällysteinen SPC 2024-04-12
|
|
PL
|
Resepti
|
Mycophenolate mofetil Hexal 250 mg kapseli, kova SPC 2024-04-05
|
|
PL
|
Resepti
|
Mycophenolate mofetil Orion 500 mg tabletti SPC 2015-04-10
|
|
PL
|
Resepti
|
Mycophenolate mofetil Sandoz 500 mg kalvopäällysteinen tabletti valmisteyhteenveto 2024-05-29
|
|
|
|
European Medicines Agency's website:
Mycophenolate mofetil Teva - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Mydrane 0,2 mg-ml + 3,1 mg-ml + 10 mg-ml injektioneste, liuos SPC 2023-09-14
|
|
PL
|
Resepti
|
Mydriasert 0,28 mg-5,4 mg silmälamelli SPC 2022-10-24
|
|
|
|
European Medicines Agency's website:
Myfenax - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Myfortic 180 mg, 360 mg enterotabletti SPC 2024-10-31
|
|
PL
|
Resepti
|
Mykronor 5 mikrog-ml injektio-infuusioneste, liuos SPC 2022-07-25
|
|
PL
|
Resepti
|
Myldrox 500 mg kapseli, kova SPC 2024-01-17
|
|
|
|
European Medicines Agency's website:
Mylotarg - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Myocet liposomal - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Myoview 230 mikrog valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2023-06-07
|
|
|
|
European Medicines Agency's website:
Myozyme - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Myrelez 60 mg, 90 mg, 120 mg injektioneste, liuos, esitäytetty ruisku valmisteyhteenveto 2024-07-25
|
|
|
|
European Medicines Agency's website:
Mysildecard - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Mysimba - EMA: EPAR PI
Finnish Swedish
|
|
|
| |
